Novartis Pharma Suisse SA published on 1st of March 2012 an important pharmacovigilance communication concerning Tégrétol (carbamazepine and its generics (Carsol CR, Neurotop retard, Timonil): before a prescription of Tégrétol (or its generics) each patient shall be tested for the presence of HLA-A*3101 allele. The aim of the test is to evaluate an individual risk […]
In collaboration with the pharmacy Sen’Su in Lausanne, we are organizing a conference focused on Genetics of food intolerances. It is taking place on 26th of April, 2012 in Lausanne.
Gene Predictis developed a unique, interactive, and user-friendly web-based portal destined to medical doctors, which allows tailoring of drug prescription in function of genetics. The portal integrates results of our genetic test CypassTM and the current knowledge on metabolism of drugs, as well as on drug-drug interactions, to ensure optimal efficiency of medicaments while reducing the risk of […]
Dr. Goranka Tanackovic joined “Gene Predictis” at CEO position from September 2011. Combining her strong entrepreneurial spirit and past experience, she is determined to further develop projects of “Gene Predictis” and contribute to its growth. Dr. Tanackovic obtained M.Sc. degree in both Biology and Chemistry from the University of Osijek, Croatia. She then studied human […]
Dr Joëlle Michaud from CIG (Lausanne) has joined Gene Predictis SA in July. Dr. Michaud who has 10 years practice in genetics and molecular biology will replace Dr Karin Brunschwig who is leaving the company in September. Dr Michaud obtained her Master in medical genetics from the University of Geneva and her PhD in medical and molecular biology in […]
Dr. Annabel McQuillan joins Gene Predictis and will bring her experience and vision on how pharmacogenetics could help to improve psychiatric medicine. Dr McQuillan was born in Edinburgh and studied medicine at the University of Glasgow. After internships in medicine and surgery she moved to Geneva to do her doctoral thesis in gastroenterology. Initially because of […]
Gene Predictis has been accepted in the Swiss Commission for Technology and Innovation (CTI) start-up coaching program. CTI promotes innovative development of young Swiss companies, providing professional expertise in business management and development. Given this support, Gene Predictis does aim to strengthen its ability to address customers’ needs in the field of pharmacogenetics and develop new solutions to offer accessible genetic passports […]
Gene Predictis’s announces a partnership with the Enterprise Management Technology Transfer EMBL Company , in Heidelberg, Germany. The EMBL is the European Centre for Molecular Biology. Cooperation aims at the development of innovative technologies to appraise, in a faster and accurate way, findings of fundamental genetics and convey them to the patient/customer. Dr Lars Steinmetz, chairman of the […]